Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
News
Latest News
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio, Warnock Reintroduce Protecting Sensitive Personal Data Act
Foreign investment is one of the legal means that adversaries, like China, can use to collect Americans’ data, exasperating both privacy and national security risks. To counter this, U.S. Senators Marco Rubio (R-FL) and Raphael Warnock (D-GA) reintroduced the...
ICYMI: Rubio Joins Special Report
U.S. Senator Marco Rubio (R-FL) joined Special Report with Bret Baier to discuss the impending government shutdown, the possibility of a Saudi-Israeli normalization deal, and the indictment of Senator Bob Menendez (D-NJ). See below for highlights and watch the full...
Rubio on DHS’ Continued Minimal Steps to Implement UFLPA
The U.S. Department of Homeland Security (DHS) announced three additions to the Uyghur Forced Labor Prevention Act (UFLPA) Entity List. These are the first additions by the Biden Administration since June. U.S. Senator Marco Rubio (R-FL), author of the bipartisan...
ICYMI: Rubio: Congress Should Think Before It Regulates AI
Congress should think before it regulates AI U.S. Senator Marco Rubio (R-FL) September 26, 2023 Washington Times To prevent next-generation computer programs from wreaking havoc on American society, [some members of Congress want] to enact comprehensive regulation at...
Rubio Urges SBA to Evaluate Chinese Ties to Competitive Research and Development Awards
Washington, D.C. — U.S. Senator Marco Rubio (R-FL), Chairman of the Senate Committee on Small Business and Entrepreneurship, sent a letter to Jovita Carranza, Administrator of the U.S. Small Business Administration (SBA), questioning the agency’s ability to ensure awardees associated with universities do not have ties to foreign governments such as China in the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The letter is in response to recent investigations by the Department of Justice and Department of Education into Dr. Charles Lieber, Chair of the Chemistry and Chemical Biology Department at Harvard University. Dr. Lieber’s company received 16 SBIR awards totaling more than $5.4 million in grants to fund his research into nanowires.
“I am alarmed that Dr. Lieber advanced his research in nanosensor and nanowire technologies with millions of dollars in non-dilutive funds from the SBIR program that enabled him to subsequently bid on, and receive, millions of dollars in federal contracts,” Chairman Rubio wrote. “I am also concerned about the seeming lack of appropriate due diligence on the part of Harvard University to assess the ties their professors have with foreign entities. It is imperative that the SBA is playing an active role, to the extent possible, in ensuring this due diligence occurs.”
The text of the letter is below.
Dear Administrator Carranza:
As you may know, recent investigations from the Department of Justice and the Department of Education have indicated that a professor at one of the country’s top universities lied about his ties to China while he was simultaneously paid large sums by Chinese entities and received millions of dollars from U.S. government agencies to fund his research. I am deeply concerned about the flow of federal research dollars, the role of the competitive Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, and the appropriate vetting by universities of their academics who are competing and bidding for these government resources.
Dr. Charles Lieber, Chair of Harvard University’s Chemistry and Chemical Biology Department, received more than $15 million to fund his research into nanowires, has been tied to China’s Thousand Talents Program, and was paid egregious sums of money from the Wuhan University of Technology (WUT). In 2001, Dr. Lieber was one of the founders of Nanosys, Inc., which received sixteen SBIR awards from 2002 to 2006 to fund research into nanosensor and nanowire projects through his lab at Harvard University. They also received funds to develop unique manufacturing processes for “high-performance electronic products” that likely helped Nanosys, Inc. commercialize their quantum dot technology and informed Dr. Lieber’s research and development work for WUT, which was focused on nanowire-based lithium ion batteries for electric vehicles. Nanosys, Inc. received SBIR awards from the Department of Defense, Department of Energy, Department of Health and Human Services, the National Aeronautics and Space Administration, and the National Science Foundation, totaling more than $5.4 million in competitive funds.
I am alarmed that Dr. Lieber advanced his research in nanosensor and nanowire technologies with millions of dollars in non-dilutive funds from the SBIR program that enabled him to subsequently bid on, and receive, millions of dollars in federal contracts. I am also concerned about the seeming lack of appropriate due diligence on the part of Harvard University to assess the ties their professors have with foreign entities. It is imperative that the Small Business Administration (SBA) is playing an active role, to the extent possible, in ensuring this due diligence occurs. Please provide the Committee with information on what oversight processes the SBA has in place over agencies participating in the SBIR and STTR programs to ensure their awardees, including those associated with universities, do not have improper ties to foreign entities, as well as what penalties exist if these relationships are uncovered. Please provide this information to the Committee by February 21, 2020.
Thank you for your attention to this important matter.
Sincerely,